← Research library

The efficacy of add-on treatment with phenotropil in adult patients with locally-induced epilepsy

Randomized study in people · 2014

What was studied
90 adults with resistant focal epilepsy; three groups of 30, adjunctive to unchanged antiepileptic therapy
Main finding
The paper reports at least 50% seizure reduction in 83% and 61% of the two active groups, alongside 32 discontinuations due to adverse events.

At least 50% seizure-frequency reduction · 83% at 200 mg/day; 61% at 100 mg/day · Published results narrative; placebo responder percentage is not supplied in the checked passage · End of treatment

Reported findings and study design

The paper reports at least 50% seizure reduction in 83% and 61% of the two active groups, alongside 32 discontinuations due to adverse events.

90 adults with resistant focal epilepsy; 30 each assigned to adjunctive 200 mg/day, 100 mg/day or placebo for three months; background antiepileptic therapy unchanged.

Population or model 90 adults with resistant focal epilepsy; three groups of 30, adjunctive to unchanged antiepileptic therapy

Results · Publisher full-text results narrative and available tables checked on 1 November 2026
MeasureResultComparison, timing and statistics
At least 50% seizure-frequency reduction83% at 200 mg/day; 61% at 100 mg/dayPublished results narrative; placebo responder percentage is not supplied in the checked passage · End of treatment
Adverse-event discontinuations12/30 at 200 mg/day; 12/30 at 100 mg/day; 8/30 with placeboCounts as reported in methods; 32/90 total withdrawals · During three-month treatment
Cognitive and mood outcomesImprovements reported; exact scale differences are in image tablesMMSE, depression, asthenia and P300 assessments; no reconstructed numbers
Withdrawal-associated EEG finding62.5% of withdrawals versus 18.8% of continuers had hypersynchronous EEG patternsAssociation across treatment groups · Correlation r=0.43; p<0.05

The text separately describes 48 active-group completers, which does not reconcile with 60 active allocations minus 24 withdrawals. Preserve reported response percentages without reconstructing their denominators or claiming a clear intention-to-treat effect. Table images and missing-data analysis remain review priorities.

Source for these results ↗ · Reviewed 2026-11-01

Study limitations and source details

Study limitations

  • The text separately describes 48 active-group completers, which does not reconcile with 60 active allocations minus 24 withdrawals. Preserve reported response percentages without reconstructing their denominators or claiming a clear intention-to-treat effect. Table images and missing-data analysis remain review priorities.
  • Adjunctive epilepsy findings do not establish effectiveness or safety in healthy users.

Source details

Publisher HTML article

Publisher full-text results narrative and available tables checked on 1 November 2026

Sources checked

Citation

Randomized trialFull text available

O. V. Grebeniuk, N. G. Zhukova, V. M. Alifirova. The efficacy of add-on treatment with phenotropil in adult patients with locally-induced epilepsy Zh Nevrol Psikhiatr Im S S Korsakova. 114(11 Pt 2):27–31

Study source ↗ · DOI 10.17116/jnevro201411411227-31 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards